FOXO1 facilitates cardiovascular development and prevents pathological remodelling during embryonic development and is the key mediator of exercise-induced physiological cardiac hypertrophy; FOXO1-deficient mouse embryos die around mid-gestation due to abnormal cardiovascular development (13–15). The gene discussed is FOXO1; the disease is cardiac hypertrophy.